Cargando…
Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B‐cell lymphoma
BACKGROUND: Cancer cachexia is known to adversely affect the clinical course in patients with malignant lymphoma. The cachexia index (CXI) is a potential biomarker of cancer cachexia, and its implications for the prognosis and treatment outcome of lung cancer and aggressive lymphoma has been assesse...
Autores principales: | Go, Se‐Il, Park, Mi Jung, Park, Sungwoo, Kang, Myoung Hee, Kim, Hoon‐Gu, Kang, Jung Hun, Kim, Jung Hoon, Lee, Gyeong‐Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718032/ https://www.ncbi.nlm.nih.gov/pubmed/34676685 http://dx.doi.org/10.1002/jcsm.12837 |
Ejemplares similares
-
Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma
por: Go, Se-Il, et al.
Publicado: (2023) -
Clinical significance of the cachexia index in patients with small cell lung cancer
por: Go, Se-Il, et al.
Publicado: (2021) -
Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma
por: Go, Se-Il, et al.
Publicado: (2020) -
A comparison of pectoralis versus lumbar skeletal muscle indices for defining sarcopenia in diffuse large B-cell lymphoma - two are better than one
por: Go, Se-Il, et al.
Publicado: (2017) -
The Endothelial Activation and Stress Index (EASIX) score is an independent prognostic factor in patients with diffuse large B-cell lymphoma
por: Park, Sungwoo, et al.
Publicado: (2022)